Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6818554 | Psychoneuroendocrinology | 2015 | 6 Pages |
Abstract
The inverse relationship between plasma MR-proADM and anxiety observed in patients with cardiovascular risk factors supports a previous experimental study using a mutant mouse line with a brain-specific loss of ADM expression which displayed hyperactive and over-anxious behavior. Further experimental and clinical studies are warranted to test the hypothesis that also in humans ADM acts as a neuromodulator with anxiolytic properties.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Thomas Meyer, Christoph Herrmann-Lingen, Mira-Lynn Chavanon, Burkert Pieske, Rolf Wachter, Frank Edelmann,